Table 1

Baseline characteristics of the 350 patients included in the PGA analysis

Age, years, median (IQR 25–75)42 (34–52), n=350
Gender (female)312 (89), n=350
Fatigue257 (73), n=350
Severe fatigue144 (41), n=350
Anxiety106 (33.5), n=316
Depression36 (12), n=304
SELENA-SLEDAI, median (IQR 25–75)4 (2–6), n=350
Hydroxychloroquine272 (80), n=340
Any GC225 (64), n=350
GC >10 mg/day65 (19), n=339
Any IS151 (43), n=350
  • All results are presented as n (%) unless stated otherwise.

  • ‘n=’ means number of patients with available data.

  • GC, glucocorticoids; IQR 25–75, 25th–75th percentile IQR; IS, immunosuppressive agent; PGA, Physician Global Assessment; SELENA, Safety of Estrogens in Lupus Erythematosus National Assessment; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.